The MHRA’s newly updated registry of medical devices with exceptional use authorisations offers three critical insights for healthcare procurement and clinical governance. First, the public documentation tracks both active exemptions and expired or cancelled authorisations, enabling providers to verify current regulatory status before device implementation. Second, the exceptional use pathway provides essential emergency access to critical medical technologies when standard regulatory processes would create dangerous delays during public health crises. Third, transparency in these authorisation processes supports informed decision-making across healthcare systems, ensuring procurement specialists and clinicians understand the regulatory context of emergency-approved devices. Healthcare organisations should utilise this registry as part of their device governance protocols, particularly when evaluating emergency medical technologies. By consulting the MHRA’s comprehensive documentation, providers can align clinical implementation with current regulatory status and maintain accountability in emergency procurement decisions. Read the full article on GMJ Newsroom.
Was this article helpful?
